Company Filing History:
Years Active: 2006-2007
Title: The Innovations of Scott Allan May
Introduction
Scott Allan May, a notable inventor based in Noblesville, Indiana, has made significant contributions to the fields of neuroscience and chemistry through his innovative patents. With a total of two patents to his name, his work focuses on advancing medical treatments and chemical processes that impact health and wellness.
Latest Patents
One of Scott's latest inventions involves excitatory amino acid receptor antagonists. This novel compound, described in his patent, offers methods for treating neurological disorders and neurodegenerative diseases, particularly addressing pain and migraine management. The invention outlines the use of compounds of Formula (I) and Formula (I(a)), as well as processes for their preparation, highlighting their potential therapeutic applications.
Another significant patent by Scott covers the synthesis of 2-aryl-1-naphthol derivatives through a tandem palladium-catalyzed arylation and dehydrogenation. This one-pot process facilitates the preparation of compounds by reacting certain chemicals in the presence of specific catalysts and solvents, exemplifying his innovative approach to pharmaceuticals and organic chemistry.
Career Highlights
Scott Allan May is associated with Eli Lilly and Company, a prominent player in the pharmaceutical industry. His work at this esteemed organization enables him to leverage cutting-edge research and innovation to develop solutions that meet the needs of patients and healthcare providers alike.
Collaborations
Throughout his career, Scott has collaborated with esteemed coworkers such as Thomas M. Wilson and Thomas John Bleisch. These partnerships exemplify a shared commitment to advancing scientific understanding and creating impactful innovations in their respective fields.
Conclusion
Scott Allan May stands out as an inventor who diligently pursues advancements in neuroscience and chemistry. Through his innovative patents and collaborative efforts, he contributes significantly to developing new treatment options and enhancing chemical methodologies, ultimately improving healthcare outcomes for many individuals.